HOME ASBESTOS DRUGS POLLUTANTS ACCIDENTS MALPRACTICE STORY OF OUR FIRM SEARCH

Clinical Trials for Mesothelioma Patients—A Study to Find the Best Dose of SU011248

Read about a current clinical trial about the use of SU011248 for patients with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only.

A Study to Find the Best Dose of SU011248 When Given With Pemetrexed, Pemetrexed and Cisplatin or Pemetrexed and Carboplatin in Patients with Advanced Solid Tumors

Purpose

This study will assess the maximum tolerated dose, overall safety and antitumor activity of SU011248 in combination with pemetrexed, pemetrexed and cisplatin or pemetrexed and carboplatin in patients with advanced solid tumors.

Phase, Condition and Intervention:

Phase I; Non-Small Cell Lung Cancer, Mesothelioma, Neoplasms; Drug: Sunitinib, Pemetrexed, Cisplatin, Carboplatin

Study Type and Design:

Interventional; Treatment, Non-Randomized, Open Label, Parallel Assignment, Safety/Efficacy Study

Official Title:

Phase I Study of SU011248 in Combination with Pemetrexed, Pemetrexed/Cisplatin and Pemetrexed/Carboplatin in Patients with Advanced Solid Malignancies

Courtesy of ClinicalTrials.gov, a service of the U.S. National Institutes of Health

If you or a loved one has been diagnosed with an Asbestos illness like mesothelioma, lung cancer or asbestosis, complete the form on this page to get a FREE and prompt review of your case by a leading Asbestos attorney. Weitz & Luxenberg is a leading mesothelioma law firm with a substantial history of success in asbestos exposure cases.

CONTACT WEITZ & LUXENBERG FOR A FREE LEGAL EVALUATION OF YOUR CASE

First Name
Last Name
Home Phone
Work Phone
City and State
Email
Were you diagnosed with Asbestosis? Yes
No
Were you diagnosed with lung cancer? Yes
No
Were you diagnosed with Mesothelioma? yes
no
What is your date of diagnosis?
Additional Comments
Best time to call?

For legal help anywhere in the U.S. call:

1 - 800 - 476 - 6070

Prior results do not guarantee a similar outcome.

ATTORNEY ADVERTISING

TABLE OF CONTENTS
Mesothelioma Mesothelioma Home Page
head Mesothelioma: An Overview
kleio The Clock Is Ticking
asbestos Our Toughest Cases
head Diagnosis
treatment Symptoms, Stages, Treatment
kleio Latest News
New York Numbers
Asbestos


IN THIS SECTION
Measures for SU011248 in mesothelioma tumors
Criteria for study in mesothelioma tumors
Contact for SU011248 trial on mesothelioma


RETURN BACK TO
Mesothelioma
Symptoms, Stages, Treatment of Mesothelioma
Treatment
Clinical trials on asbestos illness: mesothelioma
see also:

Measures for SU011248 in mesothelioma tumors Outcome measures for study of SU011248 against mesothelioma tumors
Read about measures for use of SU011248 to treat mesothelioma tumors

Criteria for study in mesothelioma tumors Study criteria of mesothelioma tumors
Read study criteria for treatment of mesothelioma tumors

Pazopanib inclusion criteria at mesothelioma trial Inclusion criteria for Pazopanib trial on mesothelioma patients
Patient inclusion criteria for Pazopanib trial against mesothelioma